← Back
$TYRA All transactions

Tyra Biosciences, Inc.

▲ BUY
6 / 10

Conviction

$ Value

$120K

Shares

11,813

Price

$10

Filed

Jun 16

Why this score? (6/10)
  • Open market buy (+3)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

RA CAPITAL MANAGEMENT, L.P.

Title

CIK

0001346824

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-06-16

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

10,259,291

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.17 to $10.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | These securities are held directly by the RA Capital Healthcare Fund, L.P. (the "Fund"). | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.09 to $10.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.12 to $10.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | These securities are held directly by the Nexus Fund. | These securities are held directly by the Account.

Filing Info

Accession No.

0001415889-25-017446

Form Type

4

Issuer CIK

0001863127

RA CAPITAL MANAGEMENT, L.P.'s History

Date Ticker Type Value
2026-04-22 ACRV A $7.0M
2026-04-20 VOR $2.7M
2026-04-17 VOR $7.5M
2026-04-15 VOR $859K
2026-04-14 VOR $2.5M
2026-04-13 VOR $8.6M
2026-04-10 VOR $13K
2026-04-09 VOR $2.2M
2026-04-08 VOR $5.8M
2026-04-08 VOR $2.2M

Other Insiders at TYRA (90d)

Insider Bought Sold Last
KAPLAN GILLA $529K 2026-03-26
Dable Habib J 2026-04-16